Testing CMTS1215 Injection for Advanced Solid Cancers
Part of Cancer clinical trials.
This early-stage trial tests a new injection called CMTS1215 in people with solid tumors (cancers that form in organs or tissues) who have tried standard treatments without success. The goal is to see if CMTS1215 can help when other options haven't worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Confirmed solid tumor with measurable lesions on imaging
- Failed or unable to complete 1st, 2nd, or 3rd-line standard cancer treatments
- Good overall health status (ECOG score 0–2: able to do light activities or better)
- Expected to live more than 3 months
- Willing to sign informed consent and participate voluntarily
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This trial tests an investigational cell therapy called HS-IT201 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if this treatment can help shrink tumors or slow their growth.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This trial tests two experimental drugs (SCTB41 and SCTB39G), given with or without standard cancer therapies, for people with advanced solid tumors that have not responded to other treatments. The goal is to see if this combination is safe and effective.
This trial tests a combination of two cell-based therapies (SCTB41 and SCTB39-1) with or without standard cancer treatments for advanced solid tumors. The goal is to see if this approach helps slow or shrink tumors while being safe enough to use in patients.
This trial tests a new drug called SCTB41 in people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and if it shrinks tumors.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.